Filing a DMF for Captisol R Excipient with the U.S. FDA
Filing a drug master file (DMF) for Captisol R Excipient can be a useful mechanism to market your
Captisol R Excipient to the U.S. Drug Industry. Typical Captisol R Excipient producers who have filed a DMF for
Captisol R Excipient include:
Registrar Corp can help you to properly prepare and submit your Captisol R Excipient DMF to FDA.
As your Agent, Registrar Corp will perform the following administrative functions:
Format, assemble and deliver your Captisol R Excipient DMF to FDA
Submit letters of authorization regarding your Captisol R Excipient to FDA
Provide changes, additions and maintenance of your Captisol R Excipient DMF
Respond to issues relating to ownership of your Captisol R Excipient DMF
Assist with submission of responses to FDA concerning your Captisol R Excipient DMF
Perform any required annual updates for your Captisol R Excipient DMF
For more information about filing a DMF for Captisol R Excipient, simply click below:
U.S. FDA Regulations:
U.S. FDA DMF Regulation: 21 C.F.R. Section 314.420
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.